Literature DB >> 12083366

NAD-dependent inhibition of the NAD-glycohydrolase activity in A549 cells.

Enrico Balducci1, Luigi G Micossi.   

Abstract

NAD glycohydrolases are enzymes that catalyze the hydrolysis of NAD to produce ADP-ribose and nicotinamide. Regulation of these enzymes has not been fully elucidated. We have identified a NAD-glycohydrolase activity associated with the outer surface of the plasma membrane in human lung epithelial cell line A549. This activity is negatively regulated by its substrate beta-NAD but not by alpha-NAD. Partial restoration of NADase activity after incubation of the cells with arginine or histidine, known ADP-ribose acceptors, suggests that inhibition be regulated by ADP-ribosylation. A549 do not undergo to apoptosis upon NAD treatment indicating that this effect be likely mediated by a cellular component(s) lacking in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083366     DOI: 10.1023/a:1015562412828

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

1.  Solubilization and comparative properties of some mammalian diphosphopyridine nucleosidases.

Authors:  N I Swislocki; M I Kalish; F I Chasalow; N O Kaplan
Journal:  J Biol Chem       Date:  1967-03-25       Impact factor: 5.157

2.  A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes.

Authors:  E Zocchi; L Franco; L Guida; U Benatti; A Bargellesi; F Malavasi; H C Lee; A De Flora
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

3.  Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells.

Authors:  F Malavasi; F Caligaris-Cappio; C Milanese; P Dellabona; P Richiardi; A O Carbonara
Journal:  Hum Immunol       Date:  1984-01       Impact factor: 2.850

4.  Self-inactivation of an erythrocyte NAD glycohydrolase.

Authors:  P H Pekala; D A Yost; B M Anderson
Journal:  Mol Cell Biochem       Date:  1980-05-28       Impact factor: 3.396

5.  Selective expression of RT6 superfamily in human bronchial epithelial cells.

Authors:  E Balducci; K Horiba; J Usuki; M Park; V J Ferrans; J Moss
Journal:  Am J Respir Cell Mol Biol       Date:  1999-09       Impact factor: 6.914

6.  Poly(ADP-ribosyl)ation of chromosomal proteins in the HeLa S3 cell cycle.

Authors:  S Tanuma; Y Kanai
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

7.  Regulation of NAD+ glycohydrolase activity by NAD(+)-dependent auto-ADP-ribosylation.

Authors:  M K Han; J Y Lee; Y S Cho; Y M Song; N H An; H R Kim; U H Kim
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase.

Authors:  J Wang; E Nemoto; A Y Kots; H R Kaslow; G Dennert
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

9.  Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.

Authors:  H Lee; W J Iglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 12.779

10.  Expression of cyclic ADP-ribose-synthetizing CD38 molecule on human platelet membrane.

Authors:  G Ramaschi; M Torti; E T Festetics; F Sinigaglia; F Malavasi; C Balduini
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  2 in total

1.  Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells.

Authors:  Mariangela Del Vecchio; Enrico Balducci
Journal:  Mol Cell Biochem       Date:  2007-12-09       Impact factor: 3.396

2.  Scant Extracellular NAD Cleaving Activity of Human Neutrophils is Down-Regulated by fMLP via FPRL1.

Authors:  Md Ashraful Hasan; Md Tipu Sultan; Won-Gyun Ahn; Yeon-Ja Kim; Ji-Hye Jang; Chang-Won Hong; Dong-Keun Song
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.